Key facts
- It has raised $130.6M; the latest was Later Stage VC ($15.1M) in Jun 2024.
- Notable investors include HV Capital, Cherry Ventures, TQ Ventures, Redalpine, Casa Verde Capital — 27 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Sanity Group
- ·The full record, as it builds
Funding rounds
No funding rounds for Sanity Group are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sanity Group
Operator of a health and life science company intended to unlock the health benefits of cannabinoids. The company is developing consumer products based on non-psychoactive cannabinoids, enabling pharmacies and clinical institutions to have access to medicinal cannabis products.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2018
- Employees
- 85
- Website
- sanitygroup.com/
- Ownership
- Privately Held (backing)
Sanity Group doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sanity Group shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sanity Group in its N-PORT filings yet. We sweep new filings monthly.